Skip to main content

BYD vs Roche: Founders, CEOs and History

BYD was founded in 1995 by Wang Chuanfu, Lu Xiangyang and is led by Wang Chuanfu. Roche was founded in 1896 by Fritz Hoffmann-La Roche and is led by Thomas Schinecker.

Company facts

BYD

Founded
1995
Headquarters
Shenzhen, Guangdong, China
Current CEO
Wang Chuanfu
Employees
911,900

Roche

Founded
1896
Headquarters
Basel, Switzerland
Current CEO
Thomas Schinecker
Employees
112,774

Founders

BYD

  • Wang Chuanfu

    Wang Chuanfu founded BYD in Shenzhen in 1995 with his cousin Lu Xiangyang to make rechargeable batteries for mobile phones.

  • Lu Xiangyang

    Lu Xiangyang put up the early capital when Wang Chuanfu started BYD in 1995 and has sat on BYD's board ever since, now as a non-executive director. His stake in BYD made him one of China's richest people.

BYD founders in full

Roche

  • Fritz Hoffmann-La Roche

    Fritz Hoffmann-La Roche (1868-1920) founded F. Hoffmann-La Roche & Co. in Basel on 1 October 1896, at age 28.

Roche founders in full

CEOs and their tenures

BYD

  1. Wang Chuanfu1995–present

    Founder, Chairman and President (CEO)

    Wang Chuanfu has run BYD since founding it in 1995. He moved the company from phone batteries into cars in 2003, launched the first mass-produced plug-in hybrid in 2008, introduced the Blade Battery in 2020 and ended combustion-only car production in 2022.

    Source
  2. Lu Xiangyang1995–present

    Co-Founder and Non-Executive Director

    Lu Xiangyang, Wang Chuanfu's cousin and a former banker, provided early capital for BYD in 1995 and has remained on the board, now as a non-executive director.

    Source
  3. Stella Li1996–present

    Executive Vice President; CEO of BYD Americas and Europe

    Stella Li joined BYD in September 1996 as a marketing manager for exports, opened its first overseas office in Hong Kong in 1997 and set up its European headquarters in 1999.

    Source
BYD CEO history in full

Roche

  1. Severin Schwan2008–2023

    Chief Executive Officer

    Serving as CEO from 2008 to 2023, he cemented Roche's absolute dominance in global oncology and highly advanced diagnostics before moving to Chairman of the Board.

    Source
  2. Thomas Schinecker2023–present

    Chief Executive Officer

    Under Schinecker, Roche returned to growth after the COVID testing decline: 2025 sales rose 7% at constant rates to ~$73.8 billion (CHF 61.5 billion) and 12 late-stage studies read out positively that year.

    Source
Roche CEO history in full

Timeline: BYD and Roche side by side

  1. 1896Roche

    F. Hoffmann-La Roche Founded in Basel

    Fritz Hoffmann-La Roche founds the enterprise in Basel, Switzerland, pioneering mass-manufactured, chemically standardized prescription pharmaceuticals.

  2. 1898Roche

    Commercial Breakthrough with Sirolin

    Roche launches non-prescription cough syrup Sirolin, achieving widespread international distribution and financing early clinical laboratories.

  3. 1934Roche

    First Industrial Synthesis of Vitamin C

    Roche becomes the first company to mass-produce synthetic Vitamin C (Redoxon) at industrial scale, anchoring decades of high-margin global cash flow.

  4. 1963Roche

    Launch of Valium (Diazepam)

    Roche introduces Valium, which becomes the world's most widely prescribed psychotropic medication and establishes global pharmaceutical leadership.

  5. 1968Roche

    Establishment of Roche Diagnostics

    Roche launches its dedicated diagnostic division, laying the foundation to become the world's preeminent in-vitro diagnostics (IVD) provider.

  6. 1995BYD

    BYD founded in Shenzhen

    Wang Chuanfu and his cousin Lu Xiangyang start BYD in Shenzhen with about 20 employees, making rechargeable batteries for mobile phones.

  7. 2000BYD

    Becomes a leading NiCd battery maker

    BYD becomes one of the world's largest makers of nickel-cadmium batteries, supplying major electronics brands.

  8. 2002BYD

    Hong Kong listing

    BYD lists its H shares on the Hong Kong Stock Exchange under stock code 1211.

  9. 2003BYD

    Buys Qinchuan and enters the car business

    BYD acquires a controlling stake in Xi'an Qinchuan Automobile for about $37.4 million (CN¥269 million), gaining a car production licence and factory.

  10. 2008BYD

    Berkshire Hathaway takes about 10%

    Berkshire Hathaway's MidAmerican Energy invests $232 million for about 10% of BYD, giving the company international credibility.

  11. 2008BYD

    Launches the F3DM plug-in hybrid

    BYD launches the F3DM, the world's first mass-produced plug-in hybrid car, two years before the Chevrolet Volt.

  12. 2008Roche

    Severin Schwan becomes CEO

    Severin Schwan became CEO of F. Hoffmann-La Roche in 2008. Led Roche for 14 years; handed over to Thomas Schinecker in March 2023 and became chairman.

  13. 2009Roche

    Full Acquisition of Genentech for $46.8 Billion

    Roche completes its historic $46.8 billion buyout of American biotechnology pioneer Genentech, securing market leadership in oncology biologics.

  14. 2010BYD

    Denza joint venture with Daimler

    BYD and Daimler set up Denza as a 50:50 joint venture to build premium electric cars in China.

  15. 2011BYD

    Launches the e6 and lists in Shenzhen

    BYD launches the e6 electric crossover, first used as a taxi in Shenzhen, and lists A shares on the Shenzhen Stock Exchange (002594).

  16. 2018Roche

    Foundation Medicine & Flatiron Health Acquisitions

    Roche acquires Foundation Medicine and Flatiron Health, integrating real-world oncology data analytics and genomic profiling into personalized healthcare.

  17. 2020BYD

    Launches the Blade Battery

    BYD introduces the Blade Battery, an LFP cell-to-pack design that passes the nail penetration test without fire.

  18. 2022BYD

    Ends combustion-only car production

    In March 2022 BYD stops making combustion-only passenger cars and focuses entirely on battery EVs and plug-in hybrids.

  19. 2023BYD

    Passes Tesla in quarterly BEV sales

    BYD sells 3.02 million new energy vehicles in 2023, and its 526,409 battery EVs in the fourth quarter top Tesla's 484,507 for the first time in a quarter.

  20. 2023Roche

    Acquired Telavant

    F. Hoffmann-La Roche acquired Telavant for $7.1 billion. Roche paid $7.1 billion upfront for Telavant to gain US and Japan rights to the anti-TL1A antibody RVT-3101 (afimkibart) for inflammatory bowel disease.

  21. 2024BYD

    Takes full ownership of Denza

    Mercedes-Benz sells its last 10% of Denza in July 2024, leaving BYD as the sole shareholder of its premium brand.

  22. 2025BYD

    Berkshire Hathaway exits

    Berkshire Hathaway confirms in September 2025 that it has sold its entire BYD stake, ending a 17-year investment.

  23. 2025BYD

    Becomes the world's top battery EV seller

    BYD sells 2.26 million battery EVs in 2025 against Tesla's 1.64 million, and 4.6 million new energy vehicles in total.

  24. 2025Roche

    Group Sales Reach CHF 61.5 Billion

    Under CEO Thomas Schinecker, Roche delivers group sales of ~$73.8 billion (CHF 61.5 billion), driven by ~$57.2B (CHF 47.7B) in Pharmaceuticals and ~$16.6B (CHF 13.8B) in Diagnostics.

  25. 2026BYD

    Unveils Blade Battery 2.0 and FLASH charging

    On March 5, 2026 BYD unveils the second-generation Blade Battery, which charges from 10% to 70% in about five minutes, and plans 20,000 FLASH charging stations in China by the end of 2026.

  26. 2026BYD

    Overseas revenue passes China

    In the first half of 2026 BYD's overseas revenue of ~$25.2 billion (CN¥181.3 billion) exceeds revenue from China for the first time, even as group revenue falls 7.1% to ~$47.9 billion (CN¥344.8 billion).

Acquisitions

BYD

  • Denza (remaining stake from Mercedes-Benz)2024Undisclosed
  • Jabil mobile electronics manufacturing business (China)2023$2B
  • Xi'an Qinchuan Automobile2003$32M
All BYD acquisitions

Roche

  • PathAI2026$1.1B
  • 89bio2025$3.5B
  • Telavant2023$7.1B
  • Carmot Therapeutics2023$2.7B
  • Foundation Medicine2018$2.4B
  • ForSight VISION42017Undisclosed
All Roche acquisitions

Questions about BYD vs Roche

Who is the CEO of BYD Company Ltd and F. Hoffmann-La Roche AG?

BYD Company Ltd is led by Wang Chuanfu and F. Hoffmann-La Roche AG is led by Thomas Schinecker. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.

When was BYD Company Ltd founded vs F. Hoffmann-La Roche AG?

F. Hoffmann-La Roche AG was founded in 1896 — 99 years before BYD Company Ltd, which was founded in 1995. F. Hoffmann-La Roche AG's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger BYD Company Ltd.

How many employees does BYD Company Ltd have compared to F. Hoffmann-La Roche AG?

BYD Company Ltd employs approximately 911,900 people, while F. Hoffmann-La Roche AG employs approximately 112,774. BYD Company Ltd has the larger workforce at 911,900 employees, compared to F. Hoffmann-La Roche AG's 112,774. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).

Where are BYD Company Ltd and F. Hoffmann-La Roche AG headquartered?

BYD Company Ltd is headquartered in China and F. Hoffmann-La Roche AG is headquartered in Switzerland. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.

Who founded BYD Company Ltd and F. Hoffmann-La Roche AG?

BYD Company Ltd was founded by Wang Chuanfu, Lu Xiangyang. F. Hoffmann-La Roche AG was founded by Fritz Hoffmann-La Roche.

Which company has a longer operating history — BYD Company Ltd or F. Hoffmann-La Roche AG?

F. Hoffmann-La Roche AG has been operating for approximately 130 years, making it the more established of the two companies. BYD Company Ltd has been in operation for around 31 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.

Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the BYD vs Roche overview

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.